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anatomically high-risk patients: Safe and durable
except for radiation-induced stenosis”
Shin et al1 described the technical feasibility and durability of
CAS in supposed medically (MED; 132 patients) or anatomically
(ANAT; 98 patients) high-risk patients using Sapphire criteria.2
Innocent readers might hail CAS as the treatment of choice in the
majority of these “high risk” patients.
The ANAT cohort (overall 30 day stroke/death rate 3%)
comprised 16 (6%) patients with previous neck radiation, who
showed an increased rate (22.2%) of restenosis. Surprisingly, the
preprocedural cerebral status of these 16 patients was not reported
separately, but less than one-third of the ANAT cohort had been
symptomatic prior to carotid artery stenting (CAS). As in Sap-
phire,2,3 “high risk for surgery” should not bemixed up with “high
risk for stroke.” Although a patient with asymptomatic 70%
stenosis with previous radiation might be considered anatomically
high risk, this patient is certainly not at high risk for stroke and
should therefore not be offered high-risk (endovascular) carotid
revascularization. The very same accounts for patients with asymp-
tomatic restenosis following prior carotid endarterectomy (CEA),
who comprised 70% of the ANAT cohort. At the level of periop-
erative risk as reported in Sapphire, all potential benefit from any
intervention ceases, and neither surgery nor angioplasty can ever
prevent long-term stroke in these asymptomatic patients.
Treating asymptomatic patients by CAS because of clinical
factors that make them high risk for other events than stroke will
do little to reduce the overall risk of stroke in the general popula-
tion. Clinicians that uncritically implement CAS justified on Sap-
phire outcomes will not do their patients any service.
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Reply
I deplore the loss of the Age of Innocence. It is obvious to any
“innocent” or open-minded reader that the purpose of this manu-
script is not to endorse liberal use of carotid artery stenting (CAS)
in asymptomatic patients, but simply to present our experience
with patients with hostile neck undergoing CAS, and, in particular,
in patients with radiation-induced stenosis. Contrary to the quoted
3% combined 30-day stroke/death rate, the actual rate in our
anatomically high-risk cohort was 2%, which highlights that CAS
can be performed safely in patients with hostile neck. In fact, this
early outcome is within the recommended threshold of 3% com-
bined stroke/death rate for carotid endarterectomy for asymptom-
atic carotid stenosis. To further correct the above letter, we do not
